Literature DB >> 21564102

Deconstructing the risk for malaria in United States donors deferred for travel to Mexico.

Bryan Spencer1, Steven Kleinman, Brian Custer, Ritchard Cable, Susan L Wilkinson, Whitney Steele, Patrick M High, David Wright.   

Abstract

BACKGROUND: More than 66,000 blood donors are deferred annually in the United States due to travel to malaria-endemic areas of Mexico. Mexico accounts for the largest share of malaria travel deferrals, yet it has extremely low risk for malaria transmission throughout most of its national territory, suggesting a suboptimal balance between blood safety and availability. This study sought to determine whether donor deferral requirements might be relaxed for parts of Mexico without compromising blood safety. STUDY DESIGN AND METHODS: Travel destination was recorded from a representative sample of presenting blood donors deferred for malaria travel from six blood centers during 2006. We imputed to these donors reporting Mexican travel a risk for acquiring malaria equivalent to Mexican residents in the destination location, adjusted for length of stay. We extrapolated these results to the overall US blood donor population.
RESULTS: Risk for malaria in Mexico varies significantly across endemic areas and is greatest in areas infrequently visited by study donors. More than 70% of blood donor deferrals were triggered by travel to the state of Quintana Roo on the Yucatán Peninsula, an area of very low malaria transmission. Eliminating the travel deferral requirement for all areas except the state of Oaxaca might result in the recovery of almost 65,000 blood donors annually at risk of approximately one contaminated unit collected every 20 years.
CONCLUSION: Deferral requirements should be relaxed for presenting donors who traveled to areas within Mexico that confer exceptionally small risks for malaria, such as Quintana Roo.
© 2011 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2011        PMID: 21564102      PMCID: PMC3645916          DOI: 10.1111/j.1537-2995.2011.03158.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  12 in total

1.  Transfusion-transmitted malaria in Canada.

Authors:  R Slinger; A Giulivi; M Bodie-Collins; F Hindieh; R S John; G Sher; M Goldman; M Ricketts; K C Kain
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

2.  A case of transfusion transmitted malaria in Switzerland.

Authors:  M Frey-Wettstein; A Maier; K Markwalder; U Münch
Journal:  Swiss Med Wkly       Date:  2001-06-02       Impact factor: 2.193

3.  Transfusion-transmitted malaria in the United States from 1963 through 1999.

Authors:  M Mungai; G Tegtmeier; M Chamberland; M Parise
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

4.  Transfusion-transmitted malaria.

Authors:  Fabrice Bruneel; Marc Thellier; Odile Eloy; Dominique Mazier; Gilbert Boulard; Martin Danis; Jean-Pierre Bédos
Journal:  Intensive Care Med       Date:  2004-07-16       Impact factor: 17.440

5.  Malaria surveillance--United States, 2004.

Authors:  Jacek Skarbinski; Eliades M James; Louise M Causer; Ann M Barber; Sonja Mali; Phuc Nguyen-Dinh; Jacquelin M Roberts; Monica E Parise; Laurence Slutsker; Robert D Newman
Journal:  MMWR Surveill Summ       Date:  2006-05-26

6.  Malaria surveillance--United States, 2003.

Authors:  M James Eliades; Snehal Shah; Phuc Nguyen-Dinh; Robert D Newman; Ann M Barber; Phuc Nguyen-Dinh; Jacquelin M Roberts; Sonja Mali; Monica E Parise; Ann M Barber; Richard Steketee
Journal:  MMWR Surveill Summ       Date:  2005-06-03

7.  Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines.

Authors:  A D Kitchen; J A J Barbara; P E Hewitt
Journal:  Vox Sang       Date:  2005-08       Impact factor: 2.144

8.  Risk for malaria in United States donors deferred for travel to malaria-endemic areas.

Authors:  Bryan Spencer; Whitney Steele; Brian Custer; Steven Kleinman; Ritchard Cable; Susan Wilkinson; David Wright
Journal:  Transfusion       Date:  2009-11       Impact factor: 3.157

9.  Malaria surveillance - United States, 2005.

Authors:  Julie Thwing; Jacek Skarbinski; Robert D Newman; Ann M Barber; Sonja Mali; Jacquelin M Roberts; Laurence Slutsker; Paul M Arguin
Journal:  MMWR Surveill Summ       Date:  2007-06-08

10.  Malaria surveillance--United States, 2002.

Authors:  Snehal Shah; Scott Filler; Louise M Causer; Alexander K Rowe; Peter B Bloland; Ann M Barber; Jacquelin M Roberts; Meghna R Desai; Monica E Parise; Richard W Steketee
Journal:  MMWR Surveill Summ       Date:  2004-04-30
View more
  5 in total

1.  The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.

Authors:  Steven Kleinman; Melissa R King; Michael P Busch; Edward L Murphy; Simone A Glynn
Journal:  Transfus Med Rev       Date:  2012-05-24

2.  Malaria blood safety policy in five non-endemic countries: a retrospective comparison through the lens of the ABO risk-based decision-making framework.

Authors:  Sheila F O'Brien; Sheila Ward; Pierre Gallian; Cécile Fabra; Josiane Pillonel; Alan D Kitchen; Katy Davison; Clive R Seed; Gilles Delage; Whitney R Steele; David A Leiby
Journal:  Blood Transfus       Date:  2019-02-06       Impact factor: 3.443

3.  Impact of changes to policy for Mexican risk travel on Canadian blood donor deferrals.

Authors:  Sheila F O'Brien; Samra Uzicanin; Karine Choquet; Qi-Long Yi; Wenli Fan; Mindy Goldman
Journal:  Blood Transfus       Date:  2013-04-22       Impact factor: 3.443

Review 4.  Alternative transmission routes in the malaria elimination era: an overview of transfusion-transmitted malaria in the Americas.

Authors:  Regina M Alho; Kim Vinícius Amaral Machado; Fernando F A Val; Nelson A Fraiji; Marcia A A Alexandre; Gisely C Melo; Judith Recht; André M Siqueira; Wuelton M Monteiro; Marcus V G Lacerda
Journal:  Malar J       Date:  2017-02-15       Impact factor: 2.979

Review 5.  Blood component recalls and market withdrawals: frequency, reasons, and management in the United States.

Authors:  Glenn Ramsey
Journal:  Transfus Med Rev       Date:  2013-02-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.